Venous Thromboses Clinical Trial
Official title:
Exercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome: ETERecaVSPT
Post-thrombotic syndrome (PTS) is the most frequently observed chronic complication of deep vein thrombosis (DVT), with an estimated cumulative incidence of 20-50%. Endovascular venous recanalization with angioplasty and stenting of obstructive lesions is the recommended treatment option to reduce or correct the symptoms of DVT. However, its impact on the physical capacity and breathlessness of patients has not been fully demonstrated. The heterogeneous evidences of clinical improvement is probably related to the presence or absence of collateral veins developed in these patients with proximal venous obstruction (iliac or iliofemoral with or without inferior vena cava involvement), which ensure the cardiac venous return. The aim of this study is to compare changes in maximal oxygen uptake after endovascular venous recanalization in DVT patients and to evaluate the hemodynamic, respiratory and muscular improvement induced by the restoration of venous flow in the occluded segments.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03613402 -
BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes
|
||
Recruiting |
NCT05409976 -
The GORE® VIAFORT Vascular Stent IVC Study
|
N/A | |
Completed |
NCT03015025 -
Pharmacogenetic Dosage Algorithm for Acenocoumarol
|
N/A | |
Completed |
NCT03911661 -
Fearon Algorithm in Warfarin Patient Self-Management
|
N/A | |
Recruiting |
NCT05449808 -
Evaluation of Thromboprophylaxis Appropriateness in Hospitalized Medical Patients
|
||
Withdrawn |
NCT05246943 -
The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients
|
||
Recruiting |
NCT01339611 -
Education Program for Patients Receiving Oral Anticoagulation
|
N/A | |
Completed |
NCT04367831 -
Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
|
Phase 4 | |
Recruiting |
NCT05711173 -
Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
|
N/A | |
Completed |
NCT04824118 -
Clotting Parameters After Medical Abortion
|
||
Withdrawn |
NCT01810237 -
Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy
|
N/A | |
Recruiting |
NCT05489588 -
The GORE® VIAFORT Vascular Stent Iliofemoral Study
|
N/A | |
Completed |
NCT05087108 -
Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow
|
Early Phase 1 | |
Terminated |
NCT04128956 -
Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS
|
Phase 2 | |
Completed |
NCT04439383 -
Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
|
||
Not yet recruiting |
NCT06452342 -
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study
|
Phase 4 | |
Recruiting |
NCT06087952 -
Leiden Thrombosis Recurrence Risk Prevention
|
N/A | |
Completed |
NCT05515120 -
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
|
Phase 2/Phase 3 | |
Completed |
NCT03611894 -
Comparison of the Radiological Pattern Between the Cerebral Stroke of Arterial and Venous Origin
|
||
Completed |
NCT03835780 -
The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
|